Glenmede Trust’s Omnicell OMCL Stock Holding History

Glenmede Trust’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,872	Closed	-$638K	–	1339
2023 Q2	$638K	Hold	10,872	–	–	﹤0.01%	769
2023 Q1	$638K	Sell	10,872 -4,873	-31%	-$269K	﹤0.01%	771
2022 Q4	$794K	Buy	15,745 +1,108	+8%	+$66.5K	﹤0.01%	714
2022 Q3	$1.27M	Buy	14,637 +3,152	+27%	+$331K	0.01%	596
2022 Q2	$1.31M	Buy	11,485 +3,645	+46%	+$418K	0.01%	608
2022 Q1	$1.01M	Buy	7,840 +2,208	+39%	+$318K	0.01%	709
2021 Q4	$1.02M	Buy	5,632 +183	+3%	+$31.7K	﹤0.01%	735
2021 Q3	$808K	Sell	5,449 -23	-0.4%	-$3.52K	﹤0.01%	757
2021 Q2	$828K	Sell	5,472 -258	-5%	-$35.9K	﹤0.01%	746
2021 Q1	$744K	Sell	5,730 -691	-11%	-$88.6K	﹤0.01%	736
2020 Q4	$770K	Buy	6,421 +337	+6%	+$33.1K	﹤0.01%	737
2020 Q3	$454K	Buy	6,084 +954	+19%	+$66.1K	﹤0.01%	815
2020 Q2	$362K	Buy	5,130 +2,922	+132%	+$200K	﹤0.01%	850
2020 Q1	$180K	Hold	2,208	–	–	﹤0.01%	1230
2019 Q4	$180K	Sell	2,208 -1,378	-38%	-$106K	﹤0.01%	1230
2019 Q3	$258	Buy	3,586 +1,848	+106%	+$136K	﹤0.01%	1075
2019 Q2	$148	Buy	1,738 +440	+34%	+$35.8K	﹤0.01%	1272
2019 Q1	$104	Sell	1,298 -2	-0.2%	-$150	﹤0.01%	1397
2018 Q4	$79	Sell	1,300 -866	-40%	-$58.6K	﹤0.01%	1422
2018 Q3	$155K	Sell	2,166 -754,800	-100%	-$47.5M	﹤0.01%	1218
2018 Q2	$39.7M	Buy	756,966 +8,600	+1%	+$404K	0.18%	193
2018 Q1	$36.3M	Hold	748,366	–	–	0.15%	206
2017 Q4	$36.3M	Sell	748,366 -7,561	-1%	-$382K	0.15%	206
2017 Q3	$38.6M	Buy	755,927 +45,997	+6%	+$2.2M	0.17%	191
2017 Q2	$28.8M	Hold	709,930	–	–	0.14%	233
2017 Q1	$28.8M	Buy	709,930 +21,166	+3%	+$780K	0.14%	233
2016 Q4	$23.3M	Sell	688,764 -163,986	-19%	-$5.64M	0.13%	261
2016 Q3	$32.7M	Sell	852,750 -200,570	-19%	-$7.48M	0.18%	177
2016 Q2	$36.1M	Buy	1,053,320 +41,957	+4%	+$1.31M	0.22%	142
2016 Q1	$28.2M	Buy	1,011,363 +242,052	+31%	+$6.65M	0.18%	186
2015 Q4	$23.9M	Buy	769,311 +693,159	+910%	+$20.5M	0.16%	206
2015 Q3	$2.37M	Buy	76,152 +91	+0.1%	+$3.26K	0.02%	562
2015 Q2	$2.87M	Sell	76,061 -29,772	-28%	-$1.09M	0.02%	495
2015 Q1	$3.71M	Buy	105,833 +23,520	+29%	+$775K	0.03%	472
2014 Q4	$2.73M	Buy	82,313 +30,960	+60%	+$956K	0.02%	510
2014 Q3	$1.4M	Buy	51,353 +1,145	+2%	+$31.4K	0.01%	617
2014 Q2	$1.44M	Sell	50,208 -632	-1%	-$17.1K	0.01%	615
2014 Q1	$1.45M	Hold	50,840	–	–	0.01%	607
2013 Q4	$1.3M	Buy	50,840 +9,771	+24%	+$233K	0.01%	615
2013 Q3	$972K	Buy	41,069 +2,162	+6%	+$48.2K	0.01%	661
2013 Q2	$798K	Buy	+38,907	New	+$718K	0.01%	672

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Glenmede Trust's OMCL Position: Q3 2023 in Review

Glenmede Trust sold out of Omnicell (OMCL) in Q3 2023, closing a stake of 10,872 shares — an estimated $638K sold.

Glenmede Trust first reported a position in OMCL in Q2 2013 and held it in 41 quarters. The position peaked at $39.7M in Q2 2018. 312 funds tracked by Wall St. Rank hold OMCL as of Q3 2023.

Glenmede Trust reported no remaining Omnicell position as of Q3 2023 after selling out during the quarter.
Glenmede Trust sold 10,872 Omnicell shares in Q3 2023, an estimated $638K.
Glenmede Trust first reported a position in Omnicell in Q2 2013 and held it in 41 quarters.
Glenmede Trust's Omnicell position peaked at $39.7M in Q2 2018.
312 funds tracked by Wall St. Rank held Omnicell as of Q3 2023.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.